RxDoctor Payments Data

Matthew Robertson, MD

Otolaryngology · Fort Collins, CONPI 1245208214

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,929 of the $2,455 with a category attached, or 78.6%. 15 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 43.0% of the total. Reporting peaked in 2022 at $1,030 and has fallen 54.6% since, to $468 in 2025.

$2,455in general payments, 2019–2025

Across 40 payments — averaging $61.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • ZOLL Medical Corporation$492
  • Stryker$191
  • Johnson & Johnson$169
  • Optinose US, Inc.$151
  • Microtransponder, Inc.$143
  • plus $253 from 9 others
$29,866in research payments, 2019–2025

Across 1 payment — averaging $29,866 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$30K

What the payments were for

  • Consulting fees$52721%
  • Food & beverage$1,92979%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,455 in reported general payments places this provider in the 70th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$140,963
Medicare patients
455
Services billed
936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,423
Azelastine Hcl34$487
Fluocinolone Acetonide Oil13$467
Montelukast Sodium22$317
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid26$252
Methylprednisolone18$94
Chlorhexidine Gluconate11$47

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →